相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Occult hemorrhage in children with severe ITP
Adolfo Flores et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Thrombopoietin Receptor Agonists Are Often Ineffective in Immune Thrombocytopenia and/or Cause Adverse Reactions: Results from One Hand
Fabian Depre et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2016)
Megakaryocyte rupture for acute platelet needs
Bernhard Nieswandt et al.
JOURNAL OF CELL BIOLOGY (2015)
IL-1α induces thrombopoiesis through megakaryocyte rupture in response to acute platelet needs
Satoshi Nishimura et al.
JOURNAL OF CELL BIOLOGY (2015)
Safety and Efficacy of Gammaplex® in Idiopathic Thrombocytopenic Purpura (ClinicalTrials.gov-NCT00504075)
Clive H. Dash et al.
PLOS ONE (2014)
Is dosing of therapeutic immunoglobulins optimal? A review of a three-decace long debate in Europe
Jacqueline Kerr et al.
FRONTIERS IN IMMUNOLOGY (2014)
Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group
Francesco Rodeghiero et al.
BLOOD (2013)
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
Cindy Neunert et al.
BLOOD (2011)
Efficacy and safety of a nanofiltered liquid intravenous immunoglobulin product in patients with primary immunodeficiency and idiopathic thrombocytopenic purpura
J. W. M. van der Meer et al.
VOX SANGUINIS (2011)
Current treatment options for primary immune thrombocytopenia
Abdulgabar Salama
EXPERT REVIEW OF HEMATOLOGY (2011)
International consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD (2010)
Efficacy and safety of a new intravenous immunoglobulin 10% formulation (octagam® 10%) in patients with immune thrombocytopenia
Tadeusz Robak et al.
HEMATOLOGY (2010)
Intravenous immunoglobulins induce potentially synergistic immunomodulations in autoimmune disorders
P. Imbach et al.
VOX SANGUINIS (2010)
The ITP syndrome: pathogenic and clinical diversity
Douglas B. Cines et al.
BLOOD (2009)
Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production
Diane Nugent et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Efficacy and safety of Privigen®, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpura
T. Robak et al.
HEMATOLOGY (2009)
Agonist-inducible platelet activation in chronic idiopathic autoimmune thrombocytopenia
Simon Panzer et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
Tolerability and safety of the intravenous immunoglobulin Octagam®:: a 10-year prospective observational study
Anette Debes et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?
Andrew R. Crow et al.
BLOOD (2007)
Immune thrombocytopenic purpura in adults
Bertrand Godeau et al.
CURRENT OPINION IN HEMATOLOGY (2007)
Management of patients with refractory immune thrombocytopenic purpura
J. . N. George
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Single dose of ANTI-D immune globulin at 75μg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children
Michael D. Tarantino et al.
JOURNAL OF PEDIATRICS (2006)
Efficacy and safety of the new intravenous immunoglobulin IGIV 10% in adults with chronic idiopathic thrombocytopenic purpura
Gyula Varga et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2006)
The molecular mechanisms that control thrombopoiesis
K Kaushansky
JOURNAL OF CLINICAL INVESTIGATION (2005)
Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children: A systematic review and meta-analysis of randomized controlled trials
CE Beck et al.
JOURNAL OF PEDIATRICS (2005)
How I treat idiopathic thrombocytopenic purpura (ITP)
DB Cines et al.
BLOOD (2005)
Relationship between platelet count and bleeding risk in thrombocytopenic patients
SJ Slichter
TRANSFUSION MEDICINE REVIEWS (2004)
Effect of maternal anti-HPA-1a antibodies and polyclonal IVIG on the activation status of vascular endothelial cells
CM Radder et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Intravenous immunoglobulin and autoimmune thrombocytopenic purpura: 22 years on
P Bierling et al.
VOX SANGUINIS (2004)
Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura:: a randomised, multicentre trial
B Godeau et al.
LANCET (2002)
分享论文
